Advanced company searchLink opens in new window

SITRYX THERAPEUTICS LIMITED

Company number 10366466

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
20 Apr 2020 SH01 Statement of capital following an allotment of shares on 30 March 2020
  • GBP 2,258.8916
16 Apr 2020 SH01 Statement of capital following an allotment of shares on 18 March 2020
  • GBP 1,851.2022
09 Apr 2020 AP01 Appointment of James Bradley Robling as a director on 30 March 2020
05 Mar 2020 TM02 Termination of appointment of Olivia Rosemary Kate Cavlan as a secretary on 28 February 2020
14 Feb 2020 SH01 Statement of capital following an allotment of shares on 7 February 2020
  • GBP 1,665.3549
19 Sep 2019 CS01 Confirmation statement made on 7 September 2019 with no updates
12 Jun 2019 AA Accounts for a small company made up to 31 December 2018
10 May 2019 AP01 Appointment of Dr Louise Kelly Modis as a director on 9 April 2019
01 Apr 2019 PSC08 Notification of a person with significant control statement
20 Feb 2019 AD01 Registered office address changed from 71 Kingsway London WC2B 6st United Kingdom to S10, Magdalen Centre 1 Robert Robinson Avenue Oxford Science Park Oxford OX4 4GA on 20 February 2019
15 Jan 2019 MR01 Registration of charge 103664660001, created on 3 January 2019
19 Sep 2018 CS01 Confirmation statement made on 7 September 2018 with updates
16 Sep 2018 TM02 Termination of appointment of Emma Tinsley as a secretary on 31 August 2018
16 Sep 2018 AP03 Appointment of Mrs Olivia Rosemary Kate Cavlan as a secretary on 31 August 2018
22 Jun 2018 SH01 Statement of capital following an allotment of shares on 1 June 2018
  • GBP 1,113.6307
12 Jun 2018 AA Total exemption full accounts made up to 31 December 2017
24 May 2018 AP01 Appointment of Andrew Neil Charles Weir as a director on 9 April 2018
01 May 2018 PSC07 Cessation of Houman Ashrafian as a person with significant control on 23 January 2018
21 Mar 2018 AP01 Appointment of Maina Bhaman as a director on 15 March 2018
21 Mar 2018 TM01 Termination of appointment of Henrijette Elsebeth Richter as a director on 15 March 2018
13 Feb 2018 AP01 Appointment of Paul-Peter Tak as a director on 23 January 2018
09 Feb 2018 TM01 Termination of appointment of Emma Tinsley as a director on 23 January 2018
09 Feb 2018 AP01 Appointment of Richard Aldrich as a director on 23 January 2018
09 Feb 2018 AP01 Appointment of Henrijette Elsebeth Richter as a director on 23 January 2018
08 Feb 2018 SH01 Statement of capital following an allotment of shares on 23 January 2018
  • GBP 8,586,447.01